Sponsor: Horizon Discovery and OnRamp BioIn this webinar—the second in the “Women in Science” series co-hosted by GEN and the Rosalind Franklin Society—pioneering microbiologist and the first woman to lead the National Science Foundation, Rita Colwell, PhD, discusses her early work in bacteriology and discoveries about how cholera survives between epidemics, with its continuing relevance today in addressing contagion, ocean science , and climate change.
Sponsor: Horizon Discovery and OnRamp BioIn this webinar—the third in the “Women in Science” series co-hosted by GEN and the Rosalind Franklin Society—renowned neuroscientist Dr. Susan Hockfield, who served as president of MIT from 2004–2012, will share her views of the future that she lays out in her recent book, The Age of Living Machines: How Biology Will Build the Next Technology Revolution.
Sponsor: Domain TherapeuticsIn this GEN webinar, our expert panelists will introduce bioSensAll™, an enhanced bystander bioluminescence resonance energy transfer (ebBRET)-based biosensor technology and its applications to interrogate RTK biology and expand current RTK drug discovery efforts.
Sponsor: Horizon DiscoveryIn this GEN webinar, sponsored by Horizon Discovery, we will hear from the experiences of two scientists working in different departments at Jounce Therapeutics that have integrated the CHOSOURCE platform to build efficiencies across their drug development workflow. Using their own experiences and case studies, our presenters will highlight the benefits of transient and stable transfections of CHO cell lines for various production purposes.
Sponsor: Horizon Discovery and OnRamp BioIn this webinar—the first in a “Women in Science” series co-hosted by GEN and the Rosalind Franklin Society—British biologist and author Dr. Matthew Cobb explores Franklin’s contribution to DNA structure and how they have been seen in popular culture. He will equally focus on the other periods in her life, highlighting the insights they provide us into the mind of one of the 20th century’s greatest scientists, one who would have celebrated her hundredth birthday this year.
Sponsor: Unchained LabsIn this GEN webinar, sponsored by Unchained Labs, you will learn about some new tools and strategies to get you answers on empty/full ratio, quantification, aggregation, and the stability of your capsids with teeny-tiny sample volumes.
Sponsor: AldevronIn this timely GEN Keynote webinar, sponsored by Aldevron, renowned AAV pioneer Dr. Guangping Gao (UMass Medical School/editor, Human Gene Therapy) will discuss the principles, history, challenges, and future directions of human gene therapy using AAVs. Dr. Gao will focus on progress in treating rare diseases and detail AAV capsid engineering to modulate target tissue tropism, therapeutic gene expression, and cassette design/optimization. Dr. Gao will also share examples of AAV gene therapy development: from proof-of-concept preclinical studies to first-in-human clinical evaluation.
Sponsor: Thermo Fisher ScientificKevin Davies, PhD, founding executive editor of The CRISPR Journal, has chronicled these events in his new book, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing. This GEN keynote webinar takes place on the official publication day of the book. Davies will share highlights and insights from his reporting over the past few years and consider some of the exciting new directions that CRISPR will empower in the years ahead.
Sponsor: Horizon DiscoveryIn this GEN webinar, sponsored by Horizon Discovery, our presenters will discuss their process for evaluating growth conditions, transfection methods, clonal cell line development, and productivity assessments. We will also hear about the gene-editing options available to customize expression hosts to suit specific needs during discovery, development, and protein production.
Sponsor: Domain TherapeuticsIn this GEN webinar, sponsored by Domain Therapeutics, we will discuss how the use of enhanced bystander bioluminescence energy transfer (ebBRET) biosensors and tag-free G protein coupled receptors (GPCRs) can help empower the discovery of next-gen therapeutics.